A Case for “Controlled Agile” Development: IXRS® Updated with Reduced Risk and In Full Regulatory Compliance
In today’s clinical trials, the need to reduce development times and costs has motivated some within the industry to re-evaluate Agile methods when developing software. This white paper presents the leading IRT provider’s experience with Agile Scrum with their own IRT and how they were able to achieve efficiency while remaining compliant in this highly regulated environment we operate in.
You will learn:
- How moving from a Waterfall methodology to an Agile-friendly SDLC can gain efficiencies
- New ways in which Regulatory requirements have evolved
- The advanced tools and technologies that enhance workflow management, change management, code quality, regression testing, document creation, and oversight